Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

TorreyPines reports results from study of NGX-426 in capsaicin-induced pain

Dec. 2, 2008

Paladin and GSK sign 3-year distribution agreement for Dexedrine for ADHD

Dec. 2, 2008

Positive results reported for novel HDAC inhibitor in experimental Huntington's disease in mice

Dec. 2, 2008

Prana provides update on research and development programs

Dec. 2, 2008

Novel dual CB1/CB2 receptor agonist efficacious in experimental pain models

Dec. 2, 2008

Lilly withdraws Cymbalta sNDA, plans to resubmit in 2009 with additional data

Dec. 1, 2008

New sodium channel blocker shows potential in models of epilepsy and psychiatric disorders

Dec. 1, 2008

Antiparkinsonian and neuroprotective effects of novel MAO-B inhibitor

Dec. 1, 2008

S-24795, an alpha7 nAChR partial agonist, may be useful in Alzheimer's disease

Dec. 1, 2008

No difference between CERE-120 and control in phase II clinical trial in PD

Dec. 1, 2008

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...